Product Information
ATORVASTATIN 80 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0692 per EA under NDC 00904629304. Its NADAC has been published 604 times since Jan 28, 2015.
FDA first approved this application on May 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904629304
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATEApproval Type
Generic (ANDA)
FDA Application
ANDA090548FDA Approved
5/29/2012
TE Code
AB
On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 80 MG TABLET has been published 604 times since Jan 28, 2015, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0692 per EA |
|---|---|
| All-time high | $0.1996 (Apr 15, 2015) |
| All-time low | $0.0635 (Jul 17, 2024) |
| 52-week high | $0.0779 |
| 52-week low | $0.0692 |
| Median price | $0.1220 |
| Average price | $0.1187 |
| Largest weekly change | -25.7% (Jul 17, 2024) |
| Weeks tracked | 604 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0692 per EA (NDC 00904629304), effective Aug 19, 2026.
How has the price of ATORVASTATIN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 60.6%. It has been tracked across 604 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?
Since Jan 28, 2015, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0635 (Jul 17, 2024) to a high of $0.1996 (Apr 15, 2015), with a median of $0.1220 per EA.
Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0635 per EA — about 8% below ATORVASTATIN 80 MG TABLET.
Who manufactures ATORVASTATIN 80 MG TABLET?
ATORVASTATIN 80 MG TABLET (NDC 00904629304) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.